Helping projects
change the future
APPLY NOW

Projects

 
 
MT-Medicals

MT-Medicals

MT-Medicals developed a highly specific inhibitor of cytochrome P450 enzymes that demonstrates high conservation, which greatly reduces the probability of tuberculosis bacterial resistance to the new treatment. Its use significantly optimizes the existing combined treatment regimens for resistant forms of tuberculosis and supports the individualization of such treatment.